◀ Back to MAPK6
HNF1B — MAPK6
Text-mined interactions from Literome
Yosimichi et al., Eur J Biochem 2001
:
These inhibitors of MAPKK and
MAPK suppressed phosphorylation of ets-like gene-1 (Elk-1) and nuclear activating
transcription factor-2 ( Atf-2 ) induced by CTGF/Hcs24 in a dose dependent manner, respectively
Faour et al., J Biol Chem 2005
(Arthritis, Rheumatoid) :
Initial studies confirmed that PGE2 induces egr-1 mRNA expression and protein synthesis by restricted SAPK2/p38
MAPK dependent activating
transcription factor-2 ( ATF-2) dimer transactivation of the egr-1 promoter as judged by studies using wild-type ( WT ) and deletion mutant egr-1 promoter constructs, Northern and Western blotting, and standard and supershift electrophoretic mobility shift analyses
Tancharoen et al., J Immunol 2005
(MAP Kinase Signaling System) :
The kinase inhibitor profile on the RgpB-neuropeptide release from HPC revealed a new PAR-2 signaling pathway that was mediated by p38
MAPK and
activated transcription factor-2 activation, in addition to the PAR-2-p44/42 p38MAPK and -AP-1 pathway
Si et al., J Virol 2005
:
JNK1/2 inhibitors reduced CVB3 induced phosphorylation of activating
transcription factor 2 , and the p38
MAPK inhibitor
reduced CVB3 induced phosphorylation of heat shock protein 27
Hisatsune et al., J Immunol 2008
:
Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent
role for
p38MAPK in activating
transcription factor-2 , cAMP response element binding protein, and NF-kappaB activation
Cho et al., Mol Endocrinol 2009
:
The inhibition of
MAPK dependent activating
transcription factor 2/c-Jun phosphorylation by GR in COX-2 repression was a result of MAPK phosphatase-1 (MKP-1) induction